Join this event to understand how digital health will drive commercial impact across life sciences!
Analyze the Five Pillars for Digital Health Value Models for Life Sciences in 2019
INVEST: Equity investments in digital health companies via corporate pharma venture or innovation funds, Acquisition (i.e., Roche's acquisition of FlatIron), Joint Venture (i.e., Sanofi + Verily forming Onduo)
INCUBATE / ACCELERATE: Internal efforts to support digital health startups (i.e., JLABS, Novartis Biome,
Bayer Grants4Apps) or support of digital health companies via external organizations (i.e., Matter + Novo, J&J + Plug & Play)
COMMERCIALIZE: Typically BD&L partnerships with digital health technology organizations that leverage the life science organization's commercialization capabilities to help bring the digital health technology to market (i.e., Novartis/Sandoz + Pear reSET-O)
COLLABORATE: Life Science collaboration with digital health companies to leverage their technologies to achieve brand and customer goals (i.e., Boehringer Ingelheim + Propeller Health)
CO-DEVELOP: Jointly developing a digital health solution, utilizing an existing platform/asset from a digital health company and the R&D capabilities from a life science organization; typically includes governmental regulatory approval (i.e., Otsuka + Proteus, Pear/Thrive + Novartis in Schizophrenia)
Speakers
- Mohammed Ali, Global Head Digital Trials- Global Clinical Operations - BOEHRINGER INGELHEIM
- Jack Barrette, CEO - WEGO HEALTH
- Priscilla Beal, Americas Head, Digital Health Partnerships - BAYER
- Fred Bennett, Head, Patient Strategy and Engagement - INTERCEPT PHARMACEUTICALS
- Aman Bhatti, Global CHC Medical Head, Digital Health and Medicines - SANOFI
- Christopher Boone, Vice President, Head of Real World Data and Analytics Center of Excellence - PFIZER
- Larry Brooks, Principal, Digital Health Practice Leader - EVOLUTION ROAD
- Megan Coder, Executive Director - DIGITAL THERAPEUTICS ALLIANCE
- Pete Dannenfelser, Associate Vice President Communications and Digital Innovation - FERRING PHARMACEUTICALS
- Melinda Decker, Former Head of Oncology and Immuno-Oncology, Digital Therapeutics and Digital Health - FORMERLY ASTRAZENECA
- David DeJonghe, Senior Director, Head of Portfolio Strategy - LIFESCAN
- Lea DeOlivera, Principal, Consulting Practice Leader - EVOLUTION ROAD
- Savan Devani, Founder and CEO - BIOTRILLION
- Jonas Dorn, Digital Solutions Director - NOVARTIS
- Juanjo Francesch, Vice President, Commercial IT - BRISTOL-MYERS SQUIBB
- Amanda Goltz, Vice President, Digital - BIOCOMPATIBLES INC., A BTG INTERNATIONAL GROUP COMPANY
- Fabio Gratton, Founder and Chief Alchemist - ALCHEMY FACTORY
- Shwen Gwee, General Manager, Digital Accelerator, Global Drug Development - NOVARTIS, USA
- Angela Horstmann, Head of Consumer Digital Experience and Innovation, U.S. PharmaCustomer Capabilities and Operations - GLAXOSMITHKLINE
- Paul Ivans, Founder and CEO - EVOLUTION ROAD
- Andy Kennemer, Vice President, Digital Customer Experience and Innovation - GLAXOSMITHKLINE
- Stefani Klaskow, Head of Industry, Healthcare - GOOGLE
- Bari Krein, J.D., LLM, Chief Strategy Officer - STARTUP HEALTH
- Gary Kurtzman, Managing Diector, Healthcare - SAFEGUARD SCIENTIFICS
- Michael Latauska, Director, Digital Health - BOEHRINGER INGELHEIM
- Bryan Mallitz, Director, Digital Health Strategy and Solutions - MERCK VACCINES
- Eddie Martucci, Ph.D., CEO and Co-Founder - AKILI INTERACTIVE
- Thomas McCourt, Chief Commercial Officer and Senior Vice President, Marketing and Sales - IRONWOOD PHARMACEUTICALS
- Alexandra McMenomy, Director, Patient Marketing - PFIZER, INC.
- Nicole Mowad-Nassar, Vice President, Commercial Analytics and Operations - ABBVIE
- James Musick, Vice President, Head of Neurology Patient Technology U.S. - UCB PHARMACEUTICALS
- Dhiren Patel, Pharm.D., Vice President of Medical Affairs - PACKHEALTH
- Nancy Phelan, Chief Business Officer - INNATE BIOLOGICS
- Stephen Ranjan, Vice President, New Product Development - ROCHE DIABETES CARE
- Roberto Roitz, Director of Strategic Partnerships, Digital Health and Analytics - HUMANA
- Brent Rose, Executive Director, Consumer/Patient Marketing I&I - CELGENE
- Sasha Said, Vice President, Digital Health investor - LEERINK TRANSFORMATION PARTNERS
- Barbara Salami, Head, Customer Experience Optimization - GLAXOSMITHKLINE
- Joel Sangerman, Chief Commercial Officer - CLICK THERAPEUTICS, INC.
- Miruna Sasu, Head of Innovation and Digital Health - BRISTOL-MYERS SQUIBB
- Melissa Saw, Global Head, Digital Partnerships - BAYER
- Daniel Seewald, Worldwide Head of Innovation - PFIZER, INC.
- Rachel Sha, Vice President, Digital Business Development - SANOFI
- Joe Slavinsky, Vice President, Business Development - PROPELLER HEALTH
- Michael C. Song, Ph.D., Senior Manager R&D, Device Functionality, Safety, and Digital Connectivity, Drug Delivery and Device Development, BioPharmaceutical Development - MEDIMMUNE
- Brian Stevens, Principal, Engagement Manager - EVOLUTION ROAD
- Unity Stoakes, Co-Founder - STARTUP HEALTH
- Ryan Sysko, CEO - AMALGAM RX, INC.
- Melissa Thomas, Director, Business Innovation - Digital Health - BOEHRINGER INGELHEIM
- Jennifer Travers, Head, Digital Review Team - PFIZER, INC.
- David Weingard, CEO - CECELIA HEALTH
- Christina Weir, Vice President, Enterprise Clinical Operations - HIGHMARK HEALTH
- Amy West, Senior Director, Patient Marketing and Digital Health Innovation - NOVO NORDISK
- Kristen Winters, Integrated Multichannel Marketing and Sales Lead, US Market - BAYER
Please fill in your name and email to receive the Conference Agenda of this event.
Venue
Sheraton Philadelphia University City Hotel
3549 Chestnut St, 19104
Philadelphia, PA, USA
Venue
Sheraton Philadelphia University City3549 Chestnut Street
Philadelphia, PA 19104
To make reservations please call 1-888-627-7071 and request the negotiated rate for ExL's Digital Health for Pharma. To make reservations online
Click HereThe group rate is available until April 8, 2019. Please book your room early as rooms available at this rate are limited.
